Typical and Atypical Hemolytic Uremic Syndrome in the Critically Ill
- PMID: 32172817
- DOI: 10.1016/j.ccc.2019.11.004
Typical and Atypical Hemolytic Uremic Syndrome in the Critically Ill
Abstract
Hemolytic uremic syndrome is characterized by microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury. Disseminated intravascular coagulation, thrombotic thrombocytopenic purpura, and hemolytic uremic syndrome have a similar clinical presentation. Diagnostic needs to be prompt to decrease mortality, because identifying the different disorders can help to tailor specific, effective therapies. However, diagnosis is challenging and morbidity and mortality remain high, especially in the critically ill population. Development of clinical prediction scores and rapid diagnostic tests for hemolytic uremic syndrome based on mechanistic knowledge are needed to facilitate early diagnosis and assign timely specific treatments to patients with hemolytic uremic syndrome variants.
Keywords: Atypical HUS; Complement-mediated HUS; Critically ill; Microangiopathy.
Copyright © 2019 Elsevier Inc. All rights reserved.
Similar articles
-
Early Differentiation of Shiga Toxin-Associated Hemolytic Uremic Syndrome in Critically Ill Adults With Thrombotic Microangiopathy Syndromes.Crit Care Med. 2018 Sep;46(9):e904-e911. doi: 10.1097/CCM.0000000000003292. Crit Care Med. 2018. PMID: 29979220
-
Where are we with haemolytic uremic syndrome?Med Clin (Barc). 2018 Oct 23;151(8):329-335. doi: 10.1016/j.medcli.2018.02.016. Epub 2018 Apr 24. Med Clin (Barc). 2018. PMID: 29699703 Review. English, Spanish.
-
Pathology Consultation on the Diagnosis and Treatment of Thrombotic Microangiopathies (TMAs).Am J Clin Pathol. 2016 Feb;145(2):158-65. doi: 10.1093/ajcp/aqv086. Am J Clin Pathol. 2016. PMID: 27124904 Review.
-
Atypical hemolytic uremic syndrome: a case report.J Med Case Rep. 2020 Jan 13;14(1):11. doi: 10.1186/s13256-019-2334-y. J Med Case Rep. 2020. PMID: 31928535 Free PMC article.
-
The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoring.Thromb Res. 2015 Nov;136(5):851-4. doi: 10.1016/j.thromres.2015.09.007. Epub 2015 Sep 12. Thromb Res. 2015. PMID: 26386489 Review.
Cited by
-
Treatment of Shiga-Toxin Hus with Severe Neurologic Features with Eculizumab.Case Rep Pediatr. 2021 Nov 13;2021:8053246. doi: 10.1155/2021/8053246. eCollection 2021. Case Rep Pediatr. 2021. PMID: 34812294 Free PMC article.
-
The role of complement in tumor immune tolerance and drug resistance: a double-edged sword.Front Immunol. 2025 Jan 31;16:1529184. doi: 10.3389/fimmu.2025.1529184. eCollection 2025. Front Immunol. 2025. PMID: 39958348 Free PMC article. Review.
-
Complement Levels at Admission Reflecting Progression to Severe Acute Kidney Injury (AKI) in Coronavirus Disease 2019 (COVID-19): A Multicenter Prospective Cohort Study.Front Med (Lausanne). 2022 Apr 29;9:796109. doi: 10.3389/fmed.2022.796109. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35572977 Free PMC article.
-
Complement levels at admission as a reflection of coronavirus disease 2019 (COVID-19) severity state.J Med Virol. 2021 Sep;93(9):5515-5522. doi: 10.1002/jmv.27077. Epub 2021 May 19. J Med Virol. 2021. PMID: 33974276 Free PMC article.
-
Underlying Genetics of aHUS: Which Connection with Outcome and Treatment Discontinuation?Int J Mol Sci. 2023 Sep 24;24(19):14496. doi: 10.3390/ijms241914496. Int J Mol Sci. 2023. PMID: 37833944 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources